Similar Items: Correction to: Therapeutic strategies for multi-resistant Escherichia coli in urinary tract infections—a cause for concern
- Therapeutic strategies for multi-resistant Escherichia coli in urinary tract infections—a cause for concern
- Carbapenem resistance in community-acquired urinary tract infections caused by Klebsiella pneumoniae and Escherichia coli in Morocco: a multicentre study (January 2022–December 2023)‘Carbapenem resistance in community UTIs in Morocco’
- Bacteremic versus Non-Bacteremic Urinary Tract Infections: Predictors of Poor Clinical Outcome
- Pharmacokinetic analysis of nacubactam, a novel β-lactamase inhibitor, co-administered with meropenem in patients with a complicated urinary tract infection
- A study of urinary tract infections in renal transplant patients
- Prognosis prediction by urinary liver-type fatty acid-binding protein in patients in the intensive care unit admitted from the emergency department: A single-center, historical cohort study